Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of cellular amide metabolic process (GO:0034250) | 7.10172788 |
2 | cytoplasmic mRNA processing body assembly (GO:0033962) | 6.16684091 |
3 | synaptic vesicle endocytosis (GO:0048488) | 6.14522948 |
4 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 4.79683583 |
5 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.67861461 |
6 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.67861461 |
7 | modulation by symbiont of host immune response (GO:0052553) | 4.67861461 |
8 | positive regulation by symbiont of host defense response (GO:0052509) | 4.67861461 |
9 | modulation by symbiont of host defense response (GO:0052031) | 4.67861461 |
10 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.67861461 |
11 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.48920529 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.48852461 |
13 | positive regulation of type 2 immune response (GO:0002830) | 4.30128357 |
14 | positive regulation of interleukin-17 production (GO:0032740) | 4.26478035 |
15 | response to pheromone (GO:0019236) | 4.23864161 |
16 | interferon-gamma production (GO:0032609) | 4.13646570 |
17 | cellular response to ATP (GO:0071318) | 4.02555130 |
18 | myeloid leukocyte mediated immunity (GO:0002444) | 3.83896707 |
19 | opioid receptor signaling pathway (GO:0038003) | 3.83695404 |
20 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.83580732 |
21 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.83005067 |
22 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.70963547 |
23 | detection of bacterium (GO:0016045) | 3.69450221 |
24 | positive regulation of defense response to virus by host (GO:0002230) | 3.65797725 |
25 | response to host immune response (GO:0052572) | 3.62710132 |
26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.62710132 |
27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.61030376 |
28 | detection of other organism (GO:0098543) | 3.60063828 |
29 | positive regulation of p38MAPK cascade (GO:1900745) | 3.58870414 |
30 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.58816014 |
31 | N-glycan processing (GO:0006491) | 3.56221413 |
32 | neutrophil mediated immunity (GO:0002446) | 3.53072035 |
33 | regulation of activation of Janus kinase activity (GO:0010533) | 3.49558780 |
34 | positive regulation of humoral immune response (GO:0002922) | 3.48634488 |
35 | nephron epithelium morphogenesis (GO:0072088) | 3.47121529 |
36 | nephron tubule morphogenesis (GO:0072078) | 3.47121529 |
37 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.46638251 |
38 | piRNA metabolic process (GO:0034587) | 3.44407539 |
39 | regulation of platelet aggregation (GO:0090330) | 3.38983937 |
40 | detection of molecule of bacterial origin (GO:0032490) | 3.37949419 |
41 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.36791173 |
42 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.33283692 |
43 | cellular biogenic amine catabolic process (GO:0042402) | 3.32770833 |
44 | amine catabolic process (GO:0009310) | 3.32770833 |
45 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.30516204 |
46 | response to host defenses (GO:0052200) | 3.30419940 |
47 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.30419940 |
48 | response to host (GO:0075136) | 3.30419940 |
49 | response to muramyl dipeptide (GO:0032495) | 3.27793343 |
50 | negative regulation of protein oligomerization (GO:0032460) | 3.27388085 |
51 | tryptophan catabolic process (GO:0006569) | 3.24475100 |
52 | indole-containing compound catabolic process (GO:0042436) | 3.24475100 |
53 | indolalkylamine catabolic process (GO:0046218) | 3.24475100 |
54 | response to peptidoglycan (GO:0032494) | 3.20811374 |
55 | nonmotile primary cilium assembly (GO:0035058) | 3.17206914 |
56 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.17201998 |
57 | epithelial cilium movement (GO:0003351) | 3.17050040 |
58 | superoxide anion generation (GO:0042554) | 3.16995192 |
59 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.15721740 |
60 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.15241090 |
61 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.14073251 |
62 | regulation of interleukin-17 production (GO:0032660) | 3.13736565 |
63 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.13670256 |
64 | behavioral response to nicotine (GO:0035095) | 3.11715297 |
65 | regulation of collateral sprouting (GO:0048670) | 3.07972846 |
66 | ganglioside metabolic process (GO:0001573) | 3.07969098 |
67 | platelet dense granule organization (GO:0060155) | 3.07752682 |
68 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.05127239 |
69 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.04515127 |
70 | microglial cell activation (GO:0001774) | 3.04495612 |
71 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.04430518 |
72 | detection of light stimulus involved in visual perception (GO:0050908) | 3.04430518 |
73 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.01036999 |
74 | regulation of cellular amide metabolic process (GO:0034248) | 3.00687709 |
75 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.00491841 |
76 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.99748200 |
77 | signal peptide processing (GO:0006465) | 2.98389039 |
78 | regulation of interferon-alpha production (GO:0032647) | 2.97570894 |
79 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.96538878 |
80 | response to ATP (GO:0033198) | 2.96051204 |
81 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.95709424 |
82 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.95709424 |
83 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.94962395 |
84 | positive regulation of heat generation (GO:0031652) | 2.94839186 |
85 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.94614968 |
86 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.94579662 |
87 | glycosphingolipid biosynthetic process (GO:0006688) | 2.93398788 |
88 | replicative senescence (GO:0090399) | 2.92643650 |
89 | immunoglobulin mediated immune response (GO:0016064) | 2.91057979 |
90 | renal tubule morphogenesis (GO:0061333) | 2.88604088 |
91 | neutrophil activation (GO:0042119) | 2.87095635 |
92 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.86383477 |
93 | macrophage activation involved in immune response (GO:0002281) | 2.86298170 |
94 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.85881783 |
95 | facial nerve structural organization (GO:0021612) | 2.85236390 |
96 | regulation of memory T cell differentiation (GO:0043380) | 2.84787031 |
97 | purinergic receptor signaling pathway (GO:0035587) | 2.81858145 |
98 | * indolalkylamine metabolic process (GO:0006586) | 2.81843441 |
99 | myeloid cell activation involved in immune response (GO:0002275) | 2.79689479 |
100 | regulation of gamma-delta T cell activation (GO:0046643) | 2.79404785 |
101 | modulation by symbiont of host cellular process (GO:0044068) | 2.78477229 |
102 | DNA deamination (GO:0045006) | 2.76715648 |
103 | sialylation (GO:0097503) | 2.74364433 |
104 | cytokine production involved in immune response (GO:0002367) | 2.73819561 |
105 | T-helper 1 type immune response (GO:0042088) | 2.72666131 |
106 | positive regulation of mast cell activation (GO:0033005) | 2.72283194 |
107 | regulation of mast cell activation (GO:0033003) | 2.71166649 |
108 | L-fucose catabolic process (GO:0042355) | 2.70700243 |
109 | fucose catabolic process (GO:0019317) | 2.70700243 |
110 | L-fucose metabolic process (GO:0042354) | 2.70700243 |
111 | adenosine receptor signaling pathway (GO:0001973) | 2.70690402 |
112 | natural killer cell activation involved in immune response (GO:0002323) | 2.70050246 |
113 | positive regulation of response to biotic stimulus (GO:0002833) | 2.68884374 |
114 | tryptophan metabolic process (GO:0006568) | 2.67894339 |
115 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67520690 |
116 | regulation of defense response to virus by host (GO:0050691) | 2.66687485 |
117 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.66641570 |
118 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.66641570 |
119 | positive regulation of antigen processing and presentation (GO:0002579) | 2.65482217 |
120 | defense response to protozoan (GO:0042832) | 2.64803835 |
121 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.63255893 |
122 | positive regulation of mRNA catabolic process (GO:0061014) | 2.63199392 |
123 | neutrophil activation involved in immune response (GO:0002283) | 2.63041193 |
124 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.62959577 |
125 | lens fiber cell differentiation (GO:0070306) | 2.61891661 |
126 | granulocyte activation (GO:0036230) | 2.61161564 |
127 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.61069040 |
128 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.59571378 |
129 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.59170036 |
130 | positive regulation of interferon-alpha production (GO:0032727) | 2.58375193 |
131 | positive regulation of interleukin-10 production (GO:0032733) | 2.58045179 |
132 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.57799344 |
133 | respiratory chain complex IV assembly (GO:0008535) | 2.57431367 |
134 | rRNA methylation (GO:0031167) | 2.57182723 |
135 | germinal center formation (GO:0002467) | 2.56630560 |
136 | phagosome maturation (GO:0090382) | 2.55885131 |
137 | regulation of interleukin-1 secretion (GO:0050704) | 2.55786278 |
138 | negative regulation of interleukin-17 production (GO:0032700) | 2.55116993 |
139 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.53879111 |
140 | regulation of hypersensitivity (GO:0002883) | 2.52721450 |
141 | mitochondrion distribution (GO:0048311) | 2.51679426 |
142 | C-terminal protein lipidation (GO:0006501) | 2.51495843 |
143 | kynurenine metabolic process (GO:0070189) | 2.49938887 |
144 | behavioral response to ethanol (GO:0048149) | 2.49669839 |
145 | adaptation of signaling pathway (GO:0023058) | 2.46438653 |
146 | detection of biotic stimulus (GO:0009595) | 2.45942109 |
147 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.45481635 |
148 | metallo-sulfur cluster assembly (GO:0031163) | 2.45248672 |
149 | iron-sulfur cluster assembly (GO:0016226) | 2.45248672 |
150 | regulation of T-helper cell differentiation (GO:0045622) | 2.45018289 |
151 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.44708408 |
152 | motile cilium assembly (GO:0044458) | 2.44072652 |
153 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.43897912 |
154 | hepatocyte differentiation (GO:0070365) | 2.43615007 |
155 | mast cell activation (GO:0045576) | 2.43122057 |
156 | positive regulation of mast cell degranulation (GO:0043306) | 2.42377452 |
157 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.42377452 |
158 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.42080446 |
159 | regulation of T-helper 1 type immune response (GO:0002825) | 2.41346002 |
160 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.40568048 |
161 | modulation by virus of host process (GO:0019054) | 2.40339848 |
162 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.40285384 |
163 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.40223911 |
164 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.40213103 |
165 | negative regulation of interleukin-12 production (GO:0032695) | 2.39891850 |
166 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.39424256 |
167 | positive regulation of developmental pigmentation (GO:0048087) | 2.38190959 |
168 | cytokine biosynthetic process (GO:0042089) | 2.38158299 |
169 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.37112704 |
170 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.37112704 |
171 | RNA destabilization (GO:0050779) | 2.36297723 |
172 | macrophage activation (GO:0042116) | 2.36256609 |
173 | developmental pigmentation (GO:0048066) | 2.34164292 |
174 | rRNA modification (GO:0000154) | 2.34032847 |
175 | neuron cell-cell adhesion (GO:0007158) | 2.33671936 |
176 | histone H3-K4 trimethylation (GO:0080182) | 2.33430021 |
177 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.33105536 |
178 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.32958316 |
179 | regulation of growth of symbiont in host (GO:0044126) | 2.32958316 |
180 | negative regulation of growth of symbiont in host (GO:0044130) | 2.32958316 |
181 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.32958316 |
182 | regulation of heat generation (GO:0031650) | 2.32165649 |
183 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.31887633 |
184 | positive regulation of interleukin-12 production (GO:0032735) | 2.31075506 |
185 | oligosaccharide catabolic process (GO:0009313) | 2.30612579 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50622681 |
2 | AR_21572438_ChIP-Seq_LNCaP_Human | 3.29607782 |
3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.05458023 |
4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.98353425 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.79983600 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.61116279 |
7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.56072748 |
8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.43940956 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.29489167 |
10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.20776638 |
11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.10326263 |
12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.09588496 |
13 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.09309059 |
14 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.04255576 |
15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02012612 |
16 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.01748553 |
17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97410663 |
18 | VDR_22108803_ChIP-Seq_LS180_Human | 1.93828831 |
19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.92288236 |
20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.88606312 |
21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.85844611 |
22 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.80838185 |
23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.70884033 |
24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70678640 |
25 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.70391188 |
26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64514585 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63197156 |
28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.62644768 |
29 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.61408469 |
30 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.59793291 |
31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.59374995 |
32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55388270 |
33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55245714 |
34 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54605967 |
35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.53365970 |
36 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.51882206 |
37 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.51882206 |
38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.51658496 |
39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.50869670 |
40 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.50606060 |
41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49632574 |
42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47867597 |
43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.47674980 |
44 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46961742 |
45 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46907795 |
46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.43726200 |
47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43651775 |
48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43549432 |
49 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.41962472 |
50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41344916 |
51 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39868702 |
52 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39680155 |
53 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.39145672 |
54 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.38413523 |
55 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.38275623 |
56 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.38206251 |
57 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.36464466 |
58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.36168247 |
59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35910849 |
60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34996396 |
61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34725441 |
62 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.34471984 |
63 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.33909672 |
64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33874778 |
65 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.33796767 |
66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33189531 |
67 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.32574904 |
68 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32574904 |
69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31967133 |
70 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.31877018 |
71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31402726 |
72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30574683 |
73 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.30240504 |
74 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.29762369 |
75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.29451482 |
76 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.29306713 |
77 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.28882532 |
78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28609065 |
79 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 1.27901460 |
80 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27720069 |
81 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.27065949 |
82 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.26568651 |
83 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.26071031 |
84 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25158409 |
85 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.25097863 |
86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24926087 |
87 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24215933 |
88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24003103 |
89 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.23616384 |
90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.23594985 |
91 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22851292 |
92 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22234429 |
93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21769337 |
94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21473989 |
95 | ERA_21632823_ChIP-Seq_H3396_Human | 1.21393501 |
96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20763476 |
97 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20627546 |
98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20351562 |
99 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.18791327 |
100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18559746 |
101 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18330241 |
102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18304450 |
103 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.17876148 |
104 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17338080 |
105 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16447160 |
106 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15473774 |
107 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14709002 |
108 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14010309 |
109 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.13932927 |
110 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13900137 |
111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13843322 |
112 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13112708 |
113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.12719534 |
114 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.12326365 |
115 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11644023 |
116 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.11563726 |
117 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11546569 |
118 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11546569 |
119 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.11001816 |
120 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10863820 |
121 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.10859596 |
122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.10739163 |
123 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10170007 |
124 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10049261 |
125 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.09360075 |
126 | EWS_26573619_Chip-Seq_HEK293_Human | 1.09227254 |
127 | P300_27268052_Chip-Seq_Bcells_Human | 1.08387694 |
128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08215727 |
129 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.08078300 |
130 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07891096 |
131 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07741634 |
132 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.06872115 |
133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06692056 |
134 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06645176 |
135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05770506 |
136 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05463984 |
137 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05175901 |
138 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04894422 |
139 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.04839017 |
140 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.04532950 |
141 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04322358 |
142 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.03723625 |
143 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.03723625 |
144 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02431148 |
145 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02430730 |
146 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01508752 |
147 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01383056 |
148 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.01230297 |
149 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00777216 |
150 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00268368 |
151 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.98841522 |
152 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.98841522 |
153 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.98768999 |
154 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.97836919 |
155 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97497614 |
156 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.97357007 |
157 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97289487 |
158 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96725370 |
159 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96285481 |
160 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96118996 |
161 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95361370 |
162 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.95075903 |
163 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94651978 |
164 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94427411 |
165 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.94075932 |
166 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92996234 |
167 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92899593 |
168 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92379046 |
169 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.91800426 |
170 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91159625 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003183_abnormal_peptide_metabolism | 4.21156364 |
2 | MP0000569_abnormal_digit_pigmentation | 4.01038051 |
3 | MP0008260_abnormal_autophagy | 3.95184511 |
4 | MP0003172_abnormal_lysosome_physiology | 3.02620956 |
5 | MP0004859_abnormal_synaptic_plasticity | 2.90721910 |
6 | MP0001986_abnormal_taste_sensitivity | 2.83750749 |
7 | MP0005171_absent_coat_pigmentation | 2.83132870 |
8 | MP0009764_decreased_sensitivity_to | 2.58080339 |
9 | MP0004782_abnormal_surfactant_physiolog | 2.44088896 |
10 | MP0009785_altered_susceptibility_to | 2.36005544 |
11 | MP0003195_calcinosis | 2.33139659 |
12 | MP0001835_abnormal_antigen_presentation | 2.20876085 |
13 | MP0006082_CNS_inflammation | 2.12454420 |
14 | MP0005387_immune_system_phenotype | 2.11704183 |
15 | MP0001790_abnormal_immune_system | 2.11704183 |
16 | MP0005551_abnormal_eye_electrophysiolog | 2.09464698 |
17 | MP0000015_abnormal_ear_pigmentation | 2.05363643 |
18 | MP0001188_hyperpigmentation | 2.03211038 |
19 | MP0003436_decreased_susceptibility_to | 2.01629804 |
20 | MP0002148_abnormal_hypersensitivity_rea | 1.98550924 |
21 | MP0005646_abnormal_pituitary_gland | 1.97109356 |
22 | MP0002933_joint_inflammation | 1.91289625 |
23 | MP0002254_reproductive_system_inflammat | 1.84895340 |
24 | MP0009745_abnormal_behavioral_response | 1.82627963 |
25 | MP0002419_abnormal_innate_immunity | 1.82110796 |
26 | MP0002736_abnormal_nociception_after | 1.79920300 |
27 | MP0005310_abnormal_salivary_gland | 1.77734519 |
28 | MP0005174_abnormal_tail_pigmentation | 1.75284304 |
29 | MP0002638_abnormal_pupillary_reflex | 1.72183054 |
30 | MP0009278_abnormal_bone_marrow | 1.68366171 |
31 | MP0005377_hearing/vestibular/ear_phenot | 1.67984015 |
32 | MP0003878_abnormal_ear_physiology | 1.67984015 |
33 | MP0005671_abnormal_response_to | 1.63708850 |
34 | MP0000371_diluted_coat_color | 1.62816478 |
35 | MP0003635_abnormal_synaptic_transmissio | 1.61707641 |
36 | MP0002063_abnormal_learning/memory/cond | 1.61368024 |
37 | MP0005503_abnormal_tendon_morphology | 1.60262336 |
38 | MP0009046_muscle_twitch | 1.59607246 |
39 | MP0005000_abnormal_immune_tolerance | 1.58339427 |
40 | MP0009697_abnormal_copulation | 1.54799262 |
41 | MP0004742_abnormal_vestibular_system | 1.51276701 |
42 | MP0002064_seizures | 1.49702695 |
43 | MP0006276_abnormal_autonomic_nervous | 1.47715145 |
44 | MP0006292_abnormal_olfactory_placode | 1.46569230 |
45 | MP0001502_abnormal_circadian_rhythm | 1.44924542 |
46 | MP0009765_abnormal_xenobiotic_induced | 1.43563946 |
47 | MP0005025_abnormal_response_to | 1.43329997 |
48 | MP0002572_abnormal_emotion/affect_behav | 1.41705714 |
49 | MP0002735_abnormal_chemical_nociception | 1.41404916 |
50 | MP0000685_abnormal_immune_system | 1.39129146 |
51 | MP0005464_abnormal_platelet_physiology | 1.38206199 |
52 | MP0002723_abnormal_immune_serum | 1.38001794 |
53 | MP0001984_abnormal_olfaction | 1.37988814 |
54 | MP0004142_abnormal_muscle_tone | 1.34671774 |
55 | MP0005167_abnormal_blood-brain_barrier | 1.34520699 |
56 | MP0005423_abnormal_somatic_nervous | 1.32961861 |
57 | MP0003045_fibrosis | 1.32585292 |
58 | MP0001486_abnormal_startle_reflex | 1.32065129 |
59 | MP0004510_myositis | 1.32001446 |
60 | MP0001800_abnormal_humoral_immune | 1.31304725 |
61 | MP0001501_abnormal_sleep_pattern | 1.30206608 |
62 | MP0005058_abnormal_lysosome_morphology | 1.28176876 |
63 | MP0002452_abnormal_antigen_presenting | 1.27452112 |
64 | MP0003880_abnormal_central_pattern | 1.27335285 |
65 | MP0002272_abnormal_nervous_system | 1.25649039 |
66 | MP0003303_peritoneal_inflammation | 1.23042562 |
67 | MP0003136_yellow_coat_color | 1.23041224 |
68 | MP0002163_abnormal_gland_morphology | 1.21006061 |
69 | MP0008872_abnormal_physiological_respon | 1.17820467 |
70 | MP0005394_taste/olfaction_phenotype | 1.17554137 |
71 | MP0005499_abnormal_olfactory_system | 1.17554137 |
72 | MP0001819_abnormal_immune_cell | 1.16769776 |
73 | MP0008469_abnormal_protein_level | 1.16575501 |
74 | MP0002876_abnormal_thyroid_physiology | 1.16386419 |
75 | MP0004381_abnormal_hair_follicle | 1.15646108 |
76 | MP0002420_abnormal_adaptive_immunity | 1.14654237 |
77 | MP0003879_abnormal_hair_cell | 1.14273829 |
78 | MP0000538_abnormal_urinary_bladder | 1.13830954 |
79 | MP0004147_increased_porphyrin_level | 1.13498116 |
80 | MP0004858_abnormal_nervous_system | 1.10977561 |
81 | MP0006072_abnormal_retinal_apoptosis | 1.10124970 |
82 | MP0002405_respiratory_system_inflammati | 1.09566754 |
83 | MP0002067_abnormal_sensory_capabilities | 1.07583124 |
84 | MP0002075_abnormal_coat/hair_pigmentati | 1.07107367 |
85 | MP0005253_abnormal_eye_physiology | 1.06755486 |
86 | MP0003279_aneurysm | 1.04837138 |
87 | MP0002928_abnormal_bile_duct | 1.04294386 |
88 | MP0002734_abnormal_mechanical_nocicepti | 1.04028940 |
89 | MP0008789_abnormal_olfactory_epithelium | 1.02702558 |
90 | MP0008875_abnormal_xenobiotic_pharmacok | 1.02472263 |
91 | MP0001177_atelectasis | 1.02250073 |
92 | MP0002653_abnormal_ependyma_morphology | 1.00439036 |
93 | MP0001533_abnormal_skeleton_physiology | 0.99774375 |
94 | MP0002938_white_spotting | 0.99767668 |
95 | MP0001968_abnormal_touch/_nociception | 0.99693969 |
96 | MP0000689_abnormal_spleen_morphology | 0.96847307 |
97 | MP0000716_abnormal_immune_system | 0.96572270 |
98 | MP0001485_abnormal_pinna_reflex | 0.96044122 |
99 | MP0004947_skin_inflammation | 0.95951045 |
100 | MP0001919_abnormal_reproductive_system | 0.94640533 |
101 | MP0003646_muscle_fatigue | 0.94239535 |
102 | MP0005390_skeleton_phenotype | 0.93924242 |
103 | MP0000566_synostosis | 0.93121751 |
104 | MP0002998_abnormal_bone_remodeling | 0.92504935 |
105 | MP0004924_abnormal_behavior | 0.92278412 |
106 | MP0005386_behavior/neurological_phenoty | 0.92278412 |
107 | MP0003011_delayed_dark_adaptation | 0.91792790 |
108 | MP0003724_increased_susceptibility_to | 0.91726456 |
109 | MP0003252_abnormal_bile_duct | 0.90825323 |
110 | MP0004885_abnormal_endolymph | 0.89615958 |
111 | MP0000343_altered_response_to | 0.89554278 |
112 | MP0001764_abnormal_homeostasis | 0.89545840 |
113 | MP0003806_abnormal_nucleotide_metabolis | 0.89466261 |
114 | MP0002102_abnormal_ear_morphology | 0.88905678 |
115 | MP0006054_spinal_hemorrhage | 0.88072090 |
116 | MP0004133_heterotaxia | 0.87787974 |
117 | MP0005410_abnormal_fertilization | 0.87563671 |
118 | MP0001324_abnormal_eye_pigmentation | 0.87205322 |
119 | MP0003787_abnormal_imprinting | 0.86740291 |
120 | MP0000858_altered_metastatic_potential | 0.85980271 |
121 | MP0005365_abnormal_bile_salt | 0.85533823 |
122 | MP0001845_abnormal_inflammatory_respons | 0.85275550 |
123 | MP0002249_abnormal_larynx_morphology | 0.84680091 |
124 | MP0008004_abnormal_stomach_pH | 0.81325713 |
125 | MP0001186_pigmentation_phenotype | 0.81175306 |
126 | MP0001970_abnormal_pain_threshold | 0.80051963 |
127 | MP0010307_abnormal_tumor_latency | 0.80029025 |
128 | MP0002332_abnormal_exercise_endurance | 0.79705639 |
129 | MP0005084_abnormal_gallbladder_morpholo | 0.79391732 |
130 | MP0002138_abnormal_hepatobiliary_system | 0.79298465 |
131 | MP0000372_irregular_coat_pigmentation | 0.78976034 |
132 | MP0000778_abnormal_nervous_system | 0.78599655 |
133 | MP0002822_catalepsy | 0.78516723 |
134 | MP0004043_abnormal_pH_regulation | 0.78010881 |
135 | MP0002398_abnormal_bone_marrow | 0.77921924 |
136 | MP0008961_abnormal_basal_metabolism | 0.77365374 |
137 | MP0000230_abnormal_systemic_arterial | 0.77054008 |
138 | MP0005379_endocrine/exocrine_gland_phen | 0.76703667 |
139 | MP0002693_abnormal_pancreas_physiology | 0.76448539 |
140 | MP0000516_abnormal_urinary_system | 0.76054520 |
141 | MP0005367_renal/urinary_system_phenotyp | 0.76054520 |
142 | MP0005397_hematopoietic_system_phenotyp | 0.75929784 |
143 | MP0001545_abnormal_hematopoietic_system | 0.75929784 |
144 | MP0008874_decreased_physiological_sensi | 0.73623055 |
145 | MP0010155_abnormal_intestine_physiology | 0.73573098 |
146 | MP0005508_abnormal_skeleton_morphology | 0.73521830 |
147 | MP0005195_abnormal_posterior_eye | 0.72070390 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Optic neuritis (HP:0100653) | 4.65061107 |
2 | Retrobulbar optic neuritis (HP:0100654) | 4.65061107 |
3 | Orchitis (HP:0100796) | 3.92809419 |
4 | Absent/shortened dynein arms (HP:0200106) | 3.85338522 |
5 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.85338522 |
6 | Scanning speech (HP:0002168) | 3.79637607 |
7 | Thick nail (HP:0001805) | 3.65163246 |
8 | Recurrent abscess formation (HP:0002722) | 3.60202233 |
9 | Protruding tongue (HP:0010808) | 3.53674442 |
10 | Congenital stationary night blindness (HP:0007642) | 3.52348369 |
11 | Stomatitis (HP:0010280) | 3.52308350 |
12 | Choroideremia (HP:0001139) | 3.49773854 |
13 | Abnormality of macrophages (HP:0004311) | 3.46072773 |
14 | Postural instability (HP:0002172) | 3.28201238 |
15 | Recurrent bacterial skin infections (HP:0005406) | 3.21392805 |
16 | Mediastinal lymphadenopathy (HP:0100721) | 3.15730320 |
17 | Supranuclear gaze palsy (HP:0000605) | 3.15697323 |
18 | Neoplasm of the adrenal cortex (HP:0100641) | 3.12628947 |
19 | Long nose (HP:0003189) | 3.10143191 |
20 | Eczematoid dermatitis (HP:0000976) | 3.09137266 |
21 | Chronic hepatic failure (HP:0100626) | 3.05615745 |
22 | Myositis (HP:0100614) | 3.03821940 |
23 | Parakeratosis (HP:0001036) | 3.02201569 |
24 | Slow saccadic eye movements (HP:0000514) | 3.00282806 |
25 | Cerebral aneurysm (HP:0004944) | 2.97605697 |
26 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.87930405 |
27 | Severe visual impairment (HP:0001141) | 2.87606874 |
28 | Stomach cancer (HP:0012126) | 2.87406399 |
29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.82789839 |
30 | Attenuation of retinal blood vessels (HP:0007843) | 2.74766613 |
31 | Abnormal hair whorl (HP:0010721) | 2.72267270 |
32 | Febrile seizures (HP:0002373) | 2.63055079 |
33 | Abnormal drinking behavior (HP:0030082) | 2.62790293 |
34 | Polydipsia (HP:0001959) | 2.62790293 |
35 | Tented upper lip vermilion (HP:0010804) | 2.61962059 |
36 | Albinism (HP:0001022) | 2.61913002 |
37 | Mild short stature (HP:0003502) | 2.60146270 |
38 | Cystic liver disease (HP:0006706) | 2.57369653 |
39 | Long foot (HP:0001833) | 2.53679859 |
40 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52393026 |
41 | Tubular atrophy (HP:0000092) | 2.52360344 |
42 | Pancreatic cysts (HP:0001737) | 2.51933378 |
43 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.50713939 |
44 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.50713939 |
45 | Pulmonary infiltrates (HP:0002113) | 2.46321556 |
46 | Submucous cleft hard palate (HP:0000176) | 2.46288610 |
47 | Abnormal ciliary motility (HP:0012262) | 2.46091438 |
48 | Vasculitis (HP:0002633) | 2.45837562 |
49 | Nephronophthisis (HP:0000090) | 2.45218563 |
50 | Keratoconjunctivitis sicca (HP:0001097) | 2.42621364 |
51 | Fetal akinesia sequence (HP:0001989) | 2.37838113 |
52 | Abolished electroretinogram (ERG) (HP:0000550) | 2.36737723 |
53 | Abnormal albumin level (HP:0012116) | 2.35704558 |
54 | Hypoalbuminemia (HP:0003073) | 2.35704558 |
55 | Medial flaring of the eyebrow (HP:0010747) | 2.32162165 |
56 | Pulmonary artery stenosis (HP:0004415) | 2.31281801 |
57 | True hermaphroditism (HP:0010459) | 2.30955247 |
58 | Plagiocephaly (HP:0001357) | 2.29898757 |
59 | Generalized hypopigmentation (HP:0007513) | 2.24995693 |
60 | Cheilitis (HP:0100825) | 2.23539958 |
61 | Xerostomia (HP:0000217) | 2.21776265 |
62 | Sensory axonal neuropathy (HP:0003390) | 2.20909566 |
63 | Retinal dysplasia (HP:0007973) | 2.18801985 |
64 | Increased IgM level (HP:0003496) | 2.18509442 |
65 | Fair hair (HP:0002286) | 2.17577375 |
66 | Hip dysplasia (HP:0001385) | 2.17325828 |
67 | Facial hemangioma (HP:0000329) | 2.17317511 |
68 | Acute necrotizing encephalopathy (HP:0006965) | 2.17307990 |
69 | Broad-based gait (HP:0002136) | 2.17185672 |
70 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.15545884 |
71 | Methylmalonic aciduria (HP:0012120) | 2.12873926 |
72 | Gingivitis (HP:0000230) | 2.12447846 |
73 | Hyperventilation (HP:0002883) | 2.11321754 |
74 | Epileptic encephalopathy (HP:0200134) | 2.11239971 |
75 | Abnormality of salivation (HP:0100755) | 2.10592453 |
76 | Abnormality of the vertebral endplates (HP:0005106) | 2.10197529 |
77 | Keratoconjunctivitis (HP:0001096) | 2.09721003 |
78 | Cortical dysplasia (HP:0002539) | 2.09280093 |
79 | Mesangial abnormality (HP:0001966) | 2.08116825 |
80 | Optic disc pallor (HP:0000543) | 2.07281076 |
81 | Hemoptysis (HP:0002105) | 2.05914254 |
82 | Polyuria (HP:0000103) | 2.05394693 |
83 | Acute hepatic failure (HP:0006554) | 2.05374260 |
84 | Hepatocellular necrosis (HP:0001404) | 2.05046526 |
85 | Drooling (HP:0002307) | 2.05000547 |
86 | Excessive salivation (HP:0003781) | 2.05000547 |
87 | Chronic bronchitis (HP:0004469) | 2.04896650 |
88 | Generalized hypopigmentation of hair (HP:0011358) | 2.03339289 |
89 | Septo-optic dysplasia (HP:0100842) | 2.02911443 |
90 | Pendular nystagmus (HP:0012043) | 2.02889294 |
91 | Rib fusion (HP:0000902) | 2.02594242 |
92 | Vacuolated lymphocytes (HP:0001922) | 2.01810771 |
93 | Impaired social interactions (HP:0000735) | 2.00982123 |
94 | Abnormal social behavior (HP:0012433) | 2.00982123 |
95 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.99892642 |
96 | Absent frontal sinuses (HP:0002688) | 1.99109126 |
97 | Congenital sensorineural hearing impairment (HP:0008527) | 1.98987599 |
98 | White forelock (HP:0002211) | 1.98694503 |
99 | Blue irides (HP:0000635) | 1.97899184 |
100 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.97299477 |
101 | Type II lissencephaly (HP:0007260) | 1.97185893 |
102 | Abnormality of the renal medulla (HP:0100957) | 1.96584468 |
103 | Decreased central vision (HP:0007663) | 1.96414711 |
104 | Increased CSF lactate (HP:0002490) | 1.96107285 |
105 | Abnormality of midbrain morphology (HP:0002418) | 1.95706053 |
106 | Molar tooth sign on MRI (HP:0002419) | 1.95706053 |
107 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.95627448 |
108 | Poor eye contact (HP:0000817) | 1.94237693 |
109 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.94175170 |
110 | Recurrent skin infections (HP:0001581) | 1.93406798 |
111 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.91818770 |
112 | Hypokinesia (HP:0002375) | 1.91106958 |
113 | Mitochondrial inheritance (HP:0001427) | 1.91104138 |
114 | Hematochezia (HP:0002573) | 1.89973112 |
115 | Obstructive lung disease (HP:0006536) | 1.88868510 |
116 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88868510 |
117 | Alveolar cell carcinoma (HP:0006519) | 1.88558721 |
118 | Hypoplastic ischia (HP:0003175) | 1.88375581 |
119 | Mutism (HP:0002300) | 1.87344916 |
120 | Leukocytosis (HP:0001974) | 1.86680153 |
121 | Gastrointestinal infarctions (HP:0005244) | 1.86267185 |
122 | Testicular atrophy (HP:0000029) | 1.84313830 |
123 | Genetic anticipation (HP:0003743) | 1.84194009 |
124 | Increased cerebral lipofuscin (HP:0011813) | 1.83944873 |
125 | Bile duct proliferation (HP:0001408) | 1.83933304 |
126 | Abnormal biliary tract physiology (HP:0012439) | 1.83933304 |
127 | Progressive macrocephaly (HP:0004481) | 1.83187291 |
128 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82990565 |
129 | Poikiloderma (HP:0001029) | 1.82568336 |
130 | Scrotal hypoplasia (HP:0000046) | 1.82189940 |
131 | Abnormality of dental color (HP:0011073) | 1.81534112 |
132 | Abnormality of the renal cortex (HP:0011035) | 1.81467732 |
133 | Peritonitis (HP:0002586) | 1.81392880 |
134 | Elfin facies (HP:0004428) | 1.80943320 |
135 | Prominent supraorbital ridges (HP:0000336) | 1.80535705 |
136 | Tachypnea (HP:0002789) | 1.80173420 |
137 | Abnormality of saccadic eye movements (HP:0000570) | 1.79130303 |
138 | Facial diplegia (HP:0001349) | 1.78668352 |
139 | Joint swelling (HP:0001386) | 1.78201035 |
140 | Renal Fanconi syndrome (HP:0001994) | 1.77921542 |
141 | Amyloidosis (HP:0011034) | 1.77318215 |
142 | Decreased circulating renin level (HP:0003351) | 1.76363954 |
143 | Acute encephalopathy (HP:0006846) | 1.76118493 |
144 | Retinitis pigmentosa (HP:0000510) | 1.75748406 |
145 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.75629688 |
146 | Pancreatic fibrosis (HP:0100732) | 1.75291675 |
147 | Nasal polyposis (HP:0100582) | 1.75243290 |
148 | Congenital primary aphakia (HP:0007707) | 1.75070452 |
149 | Keratitis (HP:0000491) | 1.74964148 |
150 | Enlarged epiphyses (HP:0010580) | 1.74873164 |
151 | Gangrene (HP:0100758) | 1.74501039 |
152 | Rectovaginal fistula (HP:0000143) | 1.73443715 |
153 | Rectal fistula (HP:0100590) | 1.73443715 |
154 | Absent speech (HP:0001344) | 1.73282865 |
155 | Hepatic necrosis (HP:0002605) | 1.73270494 |
156 | Patchy hypopigmentation of hair (HP:0011365) | 1.73059899 |
157 | Progressive cerebellar ataxia (HP:0002073) | 1.72228421 |
158 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.71956408 |
159 | Abnormality of the endocardium (HP:0004306) | 1.71266317 |
160 | Neonatal short-limb short stature (HP:0008921) | 1.70868158 |
161 | Abnormality of macular pigmentation (HP:0008002) | 1.70662414 |
162 | Tinnitus (HP:0000360) | 1.70126502 |
163 | Gait imbalance (HP:0002141) | 1.70022055 |
164 | Poor speech (HP:0002465) | 1.69836327 |
165 | Stenosis of the external auditory canal (HP:0000402) | 1.69479620 |
166 | Recurrent fungal infections (HP:0002841) | 1.68771678 |
167 | Dyschromatopsia (HP:0007641) | 1.68566473 |
168 | Cerebellar dysplasia (HP:0007033) | 1.67364753 |
169 | Decreased motor nerve conduction velocity (HP:0003431) | 1.66992136 |
170 | Irregular vertebral endplates (HP:0003301) | 1.66320552 |
171 | Hypothermia (HP:0002045) | 1.65829381 |
172 | Abnormality of the fingertips (HP:0001211) | 1.65016679 |
173 | Flat capital femoral epiphysis (HP:0003370) | 1.63376461 |
174 | Impaired smooth pursuit (HP:0007772) | 1.62934877 |
175 | Epiphyseal dysplasia (HP:0002656) | 1.60511399 |
176 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.59550004 |
177 | Hypoplasia of the fovea (HP:0007750) | 1.59550004 |
178 | Recurrent cutaneous fungal infections (HP:0011370) | 1.59104601 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ZAK | 5.15288948 |
2 | INSRR | 4.69192564 |
3 | CASK | 3.38276306 |
4 | MAP4K2 | 3.20626166 |
5 | MAP3K14 | 3.03032756 |
6 | IRAK4 | 2.99707677 |
7 | ACVR1B | 2.89147012 |
8 | FRK | 2.86803041 |
9 | RIPK4 | 2.41614011 |
10 | PRKCH | 2.38674388 |
11 | NTRK3 | 2.36661233 |
12 | NUAK1 | 2.32667401 |
13 | TLK1 | 2.23440489 |
14 | TXK | 2.18114994 |
15 | IRAK3 | 2.15396493 |
16 | BLK | 2.05336768 |
17 | NEK6 | 1.99098362 |
18 | IRAK2 | 1.96426538 |
19 | MAP2K7 | 1.95420300 |
20 | TBK1 | 1.87439789 |
21 | IKBKE | 1.86482689 |
22 | TIE1 | 1.84309871 |
23 | MST4 | 1.80877528 |
24 | BMPR1B | 1.79392142 |
25 | STK16 | 1.68560517 |
26 | PINK1 | 1.67418163 |
27 | PRPF4B | 1.65087492 |
28 | GRK1 | 1.62231918 |
29 | TRPM7 | 1.59379217 |
30 | SIK3 | 1.58671216 |
31 | MAP4K1 | 1.58059391 |
32 | ADRBK2 | 1.56797226 |
33 | MATK | 1.54937990 |
34 | EIF2AK3 | 1.52485110 |
35 | MAPK15 | 1.47036091 |
36 | NTRK2 | 1.42477537 |
37 | CDK3 | 1.39597060 |
38 | WNK3 | 1.39246512 |
39 | TEC | 1.37867095 |
40 | TRIM28 | 1.35212587 |
41 | LATS1 | 1.33910986 |
42 | ERBB3 | 1.33617726 |
43 | SGK2 | 1.32171980 |
44 | BCKDK | 1.29125878 |
45 | CSF1R | 1.26558815 |
46 | ADRBK1 | 1.25454568 |
47 | GRK7 | 1.25293371 |
48 | BMPR2 | 1.24023219 |
49 | CHUK | 1.21816344 |
50 | BTK | 1.17051091 |
51 | PLK2 | 1.04706224 |
52 | STK24 | 1.03420933 |
53 | DAPK2 | 1.02649541 |
54 | WNK1 | 1.02510296 |
55 | MAP3K12 | 1.01850987 |
56 | MAP3K4 | 1.00604057 |
57 | SGK494 | 1.00185071 |
58 | SGK223 | 1.00185071 |
59 | CAMKK2 | 1.00048505 |
60 | TAOK3 | 0.99779000 |
61 | IKBKB | 0.98333206 |
62 | PKN1 | 0.92738415 |
63 | CSK | 0.90019311 |
64 | SGK3 | 0.89775353 |
65 | PDGFRA | 0.89712937 |
66 | AKT3 | 0.89398591 |
67 | JAK1 | 0.87613065 |
68 | PDK2 | 0.84456058 |
69 | JAK3 | 0.81264804 |
70 | CSNK1G3 | 0.79330965 |
71 | YES1 | 0.78834654 |
72 | SGK1 | 0.77852150 |
73 | FGFR4 | 0.77589987 |
74 | ARAF | 0.77174319 |
75 | PIK3CA | 0.76964531 |
76 | TNK2 | 0.76571502 |
77 | MAPK7 | 0.74132579 |
78 | KIT | 0.74009338 |
79 | MARK1 | 0.73912400 |
80 | MAP3K13 | 0.72844984 |
81 | PIM2 | 0.70670221 |
82 | MAPK13 | 0.67799057 |
83 | BRSK2 | 0.67456438 |
84 | ERBB4 | 0.67101006 |
85 | TNIK | 0.66509429 |
86 | PRKCE | 0.65561244 |
87 | LYN | 0.63659748 |
88 | WNK4 | 0.63520422 |
89 | BCR | 0.63267423 |
90 | CSNK1A1L | 0.62955542 |
91 | CSNK1G1 | 0.62256593 |
92 | SYK | 0.62114661 |
93 | GRK6 | 0.61371559 |
94 | IRAK1 | 0.60840810 |
95 | PRKCQ | 0.60677055 |
96 | PLK3 | 0.59560920 |
97 | CAMK2B | 0.59499273 |
98 | FES | 0.59459549 |
99 | HCK | 0.59005899 |
100 | OXSR1 | 0.57912337 |
101 | NME2 | 0.57194733 |
102 | FGFR2 | 0.56287694 |
103 | TYK2 | 0.54934119 |
104 | JAK2 | 0.54292399 |
105 | PBK | 0.54236216 |
106 | PRKG1 | 0.54017054 |
107 | CSNK1G2 | 0.53536002 |
108 | MUSK | 0.52435728 |
109 | PRKCD | 0.50729328 |
110 | SIK2 | 0.49225966 |
111 | PAK3 | 0.48529168 |
112 | MAP3K5 | 0.47641428 |
113 | MARK3 | 0.47195813 |
114 | STK3 | 0.46885252 |
115 | ABL1 | 0.46789353 |
116 | TGFBR1 | 0.46110571 |
117 | PDGFRB | 0.45400047 |
118 | LCK | 0.44898452 |
119 | ERN1 | 0.44757140 |
120 | IGF1R | 0.44265833 |
121 | TTK | 0.44097081 |
122 | VRK1 | 0.43729913 |
123 | MINK1 | 0.43433109 |
124 | PRKCG | 0.43359561 |
125 | PIM1 | 0.42639139 |
126 | ITK | 0.41607469 |
127 | TYRO3 | 0.37131485 |
128 | PDK1 | 0.37045469 |
129 | RPS6KA2 | 0.36747887 |
130 | EIF2AK2 | 0.36309276 |
131 | VRK2 | 0.35897377 |
132 | FGFR3 | 0.35505556 |
133 | CLK1 | 0.34891061 |
134 | SRC | 0.34334619 |
135 | * PRKCA | 0.34010368 |
136 | WEE1 | 0.33892535 |
137 | MOS | 0.33866417 |
138 | GRK5 | 0.33672772 |
139 | CAMK2D | 0.33278656 |
140 | INSR | 0.31490851 |
141 | FGR | 0.30731289 |
142 | PAK6 | 0.30057103 |
143 | FGFR1 | 0.29878452 |
144 | ATR | 0.29712982 |
145 | MAP2K6 | 0.28460621 |
146 | MAPK10 | 0.27730360 |
147 | MAPKAPK5 | 0.27663260 |
148 | CDK5 | 0.27372116 |
149 | DYRK2 | 0.26508970 |
150 | CAMK2G | 0.25752173 |
151 | CAMK2A | 0.25478751 |
152 | PRKG2 | 0.25393478 |
153 | RPS6KB1 | 0.25314643 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.74603539 |
2 | Allograft rejection_Homo sapiens_hsa05330 | 2.72657131 |
3 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.38984785 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.26456713 |
5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.20504977 |
6 | Protein export_Homo sapiens_hsa03060 | 2.15618475 |
7 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.92282646 |
8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.92268200 |
9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89611265 |
10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.84907389 |
11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82720464 |
12 | Nicotine addiction_Homo sapiens_hsa05033 | 1.80916217 |
13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.78475455 |
14 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.76992965 |
15 | Phototransduction_Homo sapiens_hsa04744 | 1.76240491 |
16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.76208948 |
17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74569934 |
18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.74516412 |
19 | Sulfur relay system_Homo sapiens_hsa04122 | 1.67004928 |
20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58487577 |
21 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58049708 |
22 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.55730611 |
23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.52907572 |
24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.51680011 |
25 | Pertussis_Homo sapiens_hsa05133 | 1.51414626 |
26 | Morphine addiction_Homo sapiens_hsa05032 | 1.49988289 |
27 | Tuberculosis_Homo sapiens_hsa05152 | 1.47019123 |
28 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44413822 |
29 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.42066049 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39661455 |
31 | Malaria_Homo sapiens_hsa05144 | 1.39498632 |
32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35640993 |
33 | Measles_Homo sapiens_hsa05162 | 1.35166698 |
34 | Parkinsons disease_Homo sapiens_hsa05012 | 1.34798086 |
35 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.31618026 |
36 | Influenza A_Homo sapiens_hsa05164 | 1.31125579 |
37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.28700805 |
38 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.26493847 |
39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24837832 |
40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24767932 |
41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.24101930 |
42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.22903672 |
43 | Phagosome_Homo sapiens_hsa04145 | 1.21603160 |
44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.19068168 |
45 | Olfactory transduction_Homo sapiens_hsa04740 | 1.18407960 |
46 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.10818859 |
47 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10686414 |
48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09673862 |
49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.09521472 |
50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.09519188 |
51 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.09201265 |
52 | Taste transduction_Homo sapiens_hsa04742 | 1.08495885 |
53 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.08364308 |
54 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.06225380 |
55 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.05738722 |
56 | Peroxisome_Homo sapiens_hsa04146 | 1.05182168 |
57 | Legionellosis_Homo sapiens_hsa05134 | 1.03594123 |
58 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.02929669 |
59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01949759 |
60 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00937802 |
61 | Shigellosis_Homo sapiens_hsa05131 | 1.00908042 |
62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00408757 |
63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99637039 |
64 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.99484782 |
65 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96252377 |
66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95168834 |
67 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.93441372 |
68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93308061 |
69 | Asthma_Homo sapiens_hsa05310 | 0.93019625 |
70 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92338808 |
71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.90867806 |
72 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90543408 |
73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89504132 |
74 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87238339 |
75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.87071391 |
76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85303217 |
77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84948905 |
78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84696176 |
79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.84102691 |
80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83514188 |
81 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83106529 |
82 | Basal transcription factors_Homo sapiens_hsa03022 | 0.79884523 |
83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.79637164 |
84 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78675609 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74018433 |
86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73465584 |
87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68819949 |
88 | Apoptosis_Homo sapiens_hsa04210 | 0.68504277 |
89 | Salivary secretion_Homo sapiens_hsa04970 | 0.68415802 |
90 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68385043 |
91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.67854664 |
92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66240292 |
93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65264769 |
94 | Homologous recombination_Homo sapiens_hsa03440 | 0.64418491 |
95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63138052 |
96 | Hepatitis C_Homo sapiens_hsa05160 | 0.62999016 |
97 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.62973918 |
98 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61679012 |
99 | Insulin secretion_Homo sapiens_hsa04911 | 0.60859692 |
100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.60196814 |
101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59572280 |
102 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59063909 |
103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57929371 |
104 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.57376438 |
105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57103946 |
106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56722615 |
107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56282084 |
108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.55950679 |
109 | Salmonella infection_Homo sapiens_hsa05132 | 0.55096757 |
110 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54204072 |
111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53106989 |
112 | Lysosome_Homo sapiens_hsa04142 | 0.52641402 |
113 | ABC transporters_Homo sapiens_hsa02010 | 0.52032480 |
114 | Axon guidance_Homo sapiens_hsa04360 | 0.50329901 |
115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.48861137 |
116 | Long-term depression_Homo sapiens_hsa04730 | 0.48435349 |
117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48105538 |
118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47733016 |
119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46784857 |
120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45724599 |
121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44883476 |
122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.44060396 |
123 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43850297 |
124 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43363098 |
125 | Mineral absorption_Homo sapiens_hsa04978 | 0.42378627 |
126 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41351657 |
127 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39390247 |
128 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38154547 |
129 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38148195 |
130 | RNA polymerase_Homo sapiens_hsa03020 | 0.37964330 |
131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37450702 |
132 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.37388330 |
133 | Melanogenesis_Homo sapiens_hsa04916 | 0.37333209 |
134 | Renin secretion_Homo sapiens_hsa04924 | 0.37173698 |
135 | Hepatitis B_Homo sapiens_hsa05161 | 0.37129627 |
136 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36508288 |
137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36008339 |
138 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35019944 |
139 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34987047 |
140 | Platelet activation_Homo sapiens_hsa04611 | 0.31913442 |